natgillin/translations-raw huggingface dataset:
At the Sixth Review Conference, held in December 2006, the EU promoted full compliance with the provisions of the BTWC by all States Parties and the strengthening, where necessary, of national implementation measures, including penal legislation, and the control over pathogenic micro-organisms and toxins in the framework of the BTWC.
Na Šesti revizijski konferenci, ki je bila decembra 2006, je EU pozvala vse države pogodbenice, da v celoti spoštujejo določbe BTWC ter po potrebi okrepijo nacionalne izvedbene ukrepe, tudi kazensko pravo, in nadzor nad patogenimi mikroorganizmi in toksini v okviru BTWC.
The EU also put forward working papers, including on bio-safety and bio-security.
EU je poleg tega predložila delovne dokumente, med drugim o biološki varnosti in biološki zaščiti.
The Sixth Review Conference reaffirmed the commitment of States Parties to take the necessary national measures under Articles I, III and IV of the BTWC in order to ensure the safety and security of microbial or other biological agents or toxins in laboratories and other facilities, and during transportation, as well as to prevent unauthorised access to and removal of such agents and toxins.
Na Šesti revizijski konferenci je bila ponovno potrjena zavezanost držav pogodbenic, da sprejmejo potrebne nacionalne ukrepe v skladu s členi I, III in IV BTWC ter tako zagotovijo varnost in zaščito pred mikrobnimi in drugimi biološkimi agensi ali toksini v laboratorijih in drugih objektih ter med prevozom in preprečijo nepooblaščen dostop do takih agensov in toksinov ter njihovo nepooblaščeno odnašanje.
The Conference also urged States Parties with relevant experience in legal and administrative measures for the implementation of the provisions of the BTWC to provide assistance on the request of other State Parties.
Države pogodbenice z ustreznimi izkušnjami s pravnimi in upravnimi ukrepi za izvajanje določb BTWC so bile na konferenci pozvane, naj drugim državam pogodbenicam na njihovo prošnjo pomagajo.
The Conference encouraged such assistance on a regional basis.
Na konferenci so se zavzeli za takšno pomoč na regionalni podlagi.
The Sixth Review Conference decided to discuss, in 2008, and promote common understanding and effective action on, inter alia, national, regional and international measures to improve bio-safety and bio-security, including laboratory safety and security of pathogens and toxins.
Na Šesti revizijski konferenci je bila sprejeta odločitev, da bodo leta 2008 obravnavali in spodbujali oblikovanje enotnega stališča in učinkovito delovanje, med drugim glede nacionalnih, regionalnih in mednarodnih ukrepov za izboljšanje biološke varnosti in zaščite, tudi varnosti in zaščite pred patogeni in toksini v laboratorijih.
The Sixth Review Conference also noted, in the context of Article VII of the BTWC, that the States Parties’ national preparedness contributes to international capabilities for responding to, investigating and mitigating outbreaks of disease, including those due to alleged use of biological or toxin weapons.
Šesta revizijska konferenca je v okviru člena VII BTWC opozorila, da nacionalna pripravljenost držav pogodbenic prispeva k mednarodnim zmogljivostim za odzivanje na izbruhe bolezni, tudi bolezni, ki jih povzroči domnevna uporaba biološkega ali toksičnega orožja, ter za preiskovanje takih izbruhov in ublažitev njihovih posledic.
The Sixth Review Conference encouraged the States Parties, in the context of Article X of the BTWC, to continue strengthening existing international organisations and networks, in particular those of the World Health Organisation (WHO), the Food and Agriculture Organization (FAO), the World Organisation for Animal Health (OIE) and the International Plant Protection Convention (IPPC), called upon States Parties to continue supporting and/or improving national and regional capacities to survey, detect, diagnose and combat infectious diseases and also other possible biological threats, and urged States Parties in a position to do so to continue supporting, directly as well as through international organisations, capacity-building activities in States Parties in need of assistance in the fields of surveillance, detection, diagnosis and combat of infectious diseases, and related research.
Na Šesti revizijski konferenci so v okviru člena X BTWC spodbudili države pogodbenice, naj še naprej krepijo mednarodne organizacije in mreže, še posebej tiste, ki spadajo pod Svetovno zdravstveno organizacijo (WHO), Organizacijo za prehrano in kmetijstvo (FAO), Svetovno organizacijo za zdravje živali (OIE) in Mednarodno konvencijo za varstvo rastlin (IPPC), ter podpirajo in/ali izboljšujejo nacionalne in regionalne zmogljivosti za raziskovanje, odkrivanje, diagnosticiranje in zatiranje nalezljivih bolezni in morebitnih drugih bioloških nevarnosti; poleg tega so pozvali države pogodbenice, ki lahko nudijo podporo pri krepitvi zmogljivosti v tistih državah pogodbenicah, ki potrebujejo pomoč pri nadzorovanju, odkrivanju, diagnosticiranju in zatiranju nalezljivih bolezni ter pri raziskavah s tem v zvezi, naj s to podporo nadaljujejo, in sicer neposredno in prek mednarodnih organizacij.
On 15 June 2007, the International Health Regulation (hereinafter referred to as the IHR) entered into force.
Mednarodni zdravstveni pravilnik (v nadaljevanju „MZP“) je začel veljati 15. junija 2007.
It regulates the movement and control of and response to outbreaks of infectious diseases regardless of their origin, and requires the WHO Member States to build-up core capabilities in laboratory and surveillance to allow for the implementation of the IHR.
MZP ureja gibanje ter nadzorovanje izbruhov nalezljivih bolezni ne glede na njihov izvor in ukrepanje ob takih izbruhih ter od držav članic WHO zahteva, da vzpostavijo osnovne laboratorijske in nadzorne zmogljivosti, potrebne za izvajanje MZP.
The WHO Secretariat is committed to supporting WHO Member States to implement their IHR national plans through the WHO headquarters and regional offices, including the WHO Office in Lyon.
Sekretariat WHO se je zavezal, da bo s svojega sedeža in regionalnih uradov, tudi urada WHO v Lyonu, države članice WHO podpiral pri izvajanju njihovih nacionalnih načrtov MZP.
The WHO bio-risk reduction management programme provides guidance on how laboratories should operate through normative guidelines, workshops and training on bio-safety practices, laboratory bio-security and codes of conduct for responsible life science research.
Program WHO za upravljanje zmanjševanje bioloških nevarnosti zagotavlja usmeritve za delovanje laboratorijev, in sicer z normativnimi smernicami, delavnicami in usposabljanjem o postopkih za zagotovitev biološke varnosti, biološki zaščiti v laboratorijih in o kodeksih ravnanja pri raziskovanju na področju znanosti o življenju.
It has also a role in establishing UN guidelines on the transportation of infectious substances.
Prav tako pa igra vlogo pri pripravi smernic ZN o prevozu infektivnih snovi.
Under the IHR, public health laboratories have a role in being prepared to address biological, chemical, radiological and nuclear threats.
V skladu z MZP javnozdravstveni laboratoriji sodelujejo pri pripravljenosti na ukrepanje v primeru bioloških, kemičnih, radioloških in jedrskih nevarnosti.
The definitions for bio-safety and laboratory bio-security are encompassed in the WHO Laboratory Bio-safety Manual, third edition (2004) and the Bio-risk Management, Laboratory Bio-security Guidance (2006).
Biološka varnost in biološka zaščita v laboratorijih sta opredeljeni v priročniku WHO Laboratory Biosafety Manual, (3. izdaja, letnik 2004) in smernicah Biorisk Management, Laboratory Biosecurity Guidance (2006).
The implementation of this Joint Action shall be performed in accordance with the Financial and Administrative Framework Agreement (hereinafter referred to as ‘the Framework Agreement’) concluded between the European Commission, on the one hand, and the UN, on the other hand, which sets out a framework for the UN and the European Commission for enhancing their cooperation, including operational partnership,
Ta skupni ukrep se izvaja v skladu s finančnim in upravnim okvirnim sporazumom (v nadaljevanju „okvirni sporazum“), sklenjenim med Evropsko komisijo na eni strani in Združenimi narodi na drugi strani, ki določa okvir, v katerem bodo lahko ZN in Evropska komisija izboljšali sodelovanje, tudi operativno partnerstvo –
For the purpose of giving immediate and practical application to the relevant elements of the EU Strategy, the EU shall contribute to the implementation of decisions made by the States Parties at the Sixth Review Conference of BTWC, with the following objectives:
Da bi omogočila takojšnjo in praktično uporabo ustreznih elementov Strategije EU, EU prispeva k izvajanju odločitev, ki so jih države pogodbenice sprejele na Šesti revizijski konferenci BTWC, s temi cilji:
ensuring the safety and security of microbial or other biological agents or toxins in laboratories and other facilities, including during transportation as appropriate, in order to prevent unauthorised access to and removal of such agents and toxins;
zagotoviti varnost in zaščito pred mikrobnimi in drugimi biološkimi agensi ali toksini v laboratorijih in drugih objektih ter po potrebi med prevozom in tako preprečiti nepooblaščen dostop do takih agensov in toksinov ter njihovo nepooblaščeno odnašanje;
promoting bio-risk reduction practices and awareness, including bio-safety, bio-security, bioethics and preparedness against intentional misuse of biological agents and toxins, through international cooperation in this area.
z mednarodnim sodelovanjem na tem področju spodbujati ozaveščanje in dejavnosti za zmanjšanje bioloških nevarnosti, med drugim biološko varnost, biološko zaščito, bioetiko in pripravljenost na ukrepanje proti zlorabam bioloških agensov in toksinov.
To achieve the objectives referred to in paragraph 1, the EU shall introduce projects consisting of the following measures:
EU za doseganje ciljev iz odstavka 1 uvede projekte s temi ukrepi:
organisation of outreach workshops, consultations and training for competent authorities in the relevant sectors and for laboratory managers/staff at the national, sub-regional and regional levels, aiming at a deeper understanding of bio-risk reduction practices and their effective implementation in laboratories and other facilities, including during transportation as appropriate;
organizacija delavnic za ozaveščanje, posvetovanj in usposabljanj, namenjenih pristojnim organom v ustreznih sektorjih in upravam/uslužbencem laboratorijev na nacionalni, podregionalni in regionalni ravni; njihov cilj je izboljšati poznavanje in učinkovitost izvajanja dejavnosti za zmanjševanje bioloških nevarnosti v laboratorijih in drugih objektih, po potrebi tudi med prevozom;
assistance to a selected country to review public health response capacity in the context of enhancing national biological preparedness, to develop and implement a bio-risk reduction management plan, particularly concerning laboratory practice and safety, and to harmonise it with integrated national preparedness plans, and to strengthen the performance and sustainability of national laboratories by connecting them with regional and international networks.
pomoč izbrani državi pri preverjanju odzivne sposobnosti v primeru nevarnosti za javno zdravje v okviru izboljševanja nacionalne pripravljenosti na biološke nevarnosti, pri pripravljanju in izvajanju načrta upravljanja za zmanjšanje bioloških nevarnosti, še zlasti glede laboratorijske prakse in varnosti, in njihovem usklajevanju s celovitimi nacionalnimi načrti pripravljenosti, ter izboljšanju delovanja in finančne vzdržnosti nacionalnih laboratorijev prek njihovega povezovanja z regionalnimi in mednarodnimi mrežami.
A detailed description of these projects is set out in the Annex to this Joint Action.
Projekti so podrobno opisani v Prilogi k temu skupnemu ukrepu.
The Presidency, assisted by the Secretary-General/High Representative (hereinafter referred to as the SG/HR), shall be responsible for the implementation of this Joint Action.
Za izvajanje tega skupnega ukrepa je odgovorno predsedstvo ob pomoči generalnega sekretarja/visokega predstavnika (v nadaljevanju „GS/VP“).
The Commission shall be fully associated.
Komisija je v ta postopek v celoti vključena.
The technical implementation of the measures referred to in Article 1(2) shall be carried out by the WHO, which includes the WHO Office in Lyon.
Za tehnično izvedbo ukrepov iz člena 1(2) je odgovorna WHO skupaj z uradom WHO v Lyonu.
The WHO shall perform its tasks under the control of the SG/HR assisting the Presidency.
WHO svoje naloge izvaja pod nadzorom GS/VP, ki pomaga predsedstvu.
For this purpose, the SG/HR shall enter into the necessary arrangements with the WHO.
V ta namen GS/VP z WHO sklene potrebne dogovore.
The Presidency, assisted by the SG/HR, and the Commission shall keep each other regularly informed about the implementation of this Joint Action, in conformity with their respective competences.
Predsedstvo, GS/VP in Komisija drug drugega redno obveščajo o izvajanju tega skupnega ukrepa v skladu s svojimi pristojnostmi.
The financial reference amount for the implementation of the measures referred to in Article 1(2) shall be EUR 2105000, to be funded from the general budget of the European Union.
Referenčni finančni znesek za izvajanje ukrepov iz člena 1(2) v višini 2105000 EUR bo financiran iz splošnega proračuna Evropske unije za leto 2007.
The expenditure financed by the amount stipulated in paragraph 1 shall be managed in accordance with the Community procedures and rules applicable to the general budget of the European Union.
Odhodki, ki se financirajo iz zneska, določenega v odstavku 1, se upravljajo v skladu s postopki in pravili Evropske skupnosti, ki se uporabljajo za splošni proračun Evropskih skupnosti.
For this purpose, the Commission shall conclude a financing agreement with the WHO.
Komisija v ta namen sklene sporazum o financiranju z WHO.
The financing agreement shall stipulate that the WHO is to ensure that the visibility of the EU contribution is appropriate to its size, including by participation of EU experts.
V sporazumu o financiranju je določeno, da bo WHO zagotovila razpoznavnost prispevka EU, ustrezno njegovi višini, tudi z udeležbo strokovnjakov EU.
It shall inform the Council of any difficulties in that process and of the date of conclusion of the financing agreement.
Komisija Svet obvesti o kakršnih koli težavah v tem postopku in o datumu sklenitve sporazuma o financiranju.
The Presidency, assisted by the SG/HR, shall report to the Council on the implementation of this Joint Action on the basis of quarterly reports prepared by the WHO.
Predsedstvo, ki mu pomaga GS/VP, poroča Svetu o izvajanju tega skupnega ukrepa na podlagi četrtletnih poročil WHO.
These reports will form the basis for the evaluation carried out by the Council.
Ta poročila bodo podlaga za ocenjevanje, ki ga bo opravil Svet.
It shall report to the Council on the financial aspects of the implementation of this Joint Action.
Svetu poroča o finančnih vidikih izvajanja tega skupnega ukrepa.
It shall expire 24 months after the date of conclusion of the financing agreement referred to in Article 3(3), or six months after the date of its adoption if no financing agreement has been concluded by then.
Veljati preneha 24 mesecev po dnevu sklenitve sporazuma o financiranju iz člena 3(3) ali 6 mesecev po dnevu sprejetja, če v tem času ni sklenjen sporazum o financiranju.
OJ L 65, 7.3.2006, p. 51.
UL L 65, 7.3.2006, str. 51.
OJ C 57, 9.3.2006, p. 1.
UL C 57, 9.3.2006, str. 1.
OJ L 88, 25.3.2006, p. 65.
UL L 88, 25.3.2006, str. 65.
DESCRIPTION OF THE PROJECTS TO BE FINANCED
OPIS FINANCIRANIH PROJEKTOV:
The overall objective of this Joint Action is to support, through the projects described below, the implementation of the BTWC, in particular those aspects that relate to the safety and security of microbial or other biological agents and toxins in laboratories and other facilities, including during transportation as appropriate, in order to prevent unauthorised access to and removal of such agents and toxins.
Glavni cilj tega skupnega ukrepa je s projekti, opisanimi v nadaljevanju, podpirati izvajanje BTWC, predvsem vidikov v zvezi z varnostjo in zaščito pred mikrobnimi in drugimi biološkimi agensi in toksini v laboratorijih in drugih objektih, po potrebi tudi med prevozom, ter tako preprečiti nepooblaščen dostop do teh agensov in toksinov in njihovo nepooblaščeno odnašanje.
It is also to contribute to raising awareness of bio-risk management practices and to promote, especially through Project 2, the harmonisation of good national laboratory practices and biological agent response with overall national biological preparedness.
Poleg tega naj bi prispeval k ozaveščanju o dejavnostih obvladovanja bioloških nevarnosti, predvsem s Projektom 2 pa spodbudil tudi dobre nacionalne laboratorijske prakse in ustrezno ukrepanje ob pojavu bioloških agensov, ki bo usklajeno s splošno nacionalno pripravljenostjo na biološko nevarnost.
Project-based specific objectives
Posebni projektni cilji
The projects described below will address three areas of major concern in the accidental and deliberate spread of diseases:
Projekti iz nadaljevanja se bodo ukvarjali s tremi zaskrbljujočimi področji nenamernega in namernega širjenja bolezni:
The risk of terrorists or other criminals having access to dangerous biological pathogens/toxins.
Nevarnost, da bi teroristi ali drugi zločinci imeli dostop do nevarnih bioloških patogenov/toksinov.
The intention of terrorists to acquire and to use the disease as a weapon must be contained.
Treba je preprečiti namere teroristov, da pridobijo bolezen in jo uporabijo kot orožje.
Such events as the anthrax spore-laden letters in the US in 2001 have the potential to create huge political and economic disturbances.
Dogodki, kot so bila pisma z antraksom leta 2001 v ZDA, lahko povzročijo zelo velike politične in gospodarske težave.
A considerable increase in new laboratories in general, but in particular in high-level containment laboratories which lag behind in respecting adequate bio-safety and bio-security standards.
Znatno povečanje števila novih laboratorijev nasploh in predvsem laboratorijev s potrebno visoko stopnjo biološke varnosti in biološke zaščite, ki prepočasi izpolnjujejo ustrezne standarde biološke varnosti in biološke zaščite.
In recent years, a considerable number of countries, including countries which have limited resources, have allocated funds to construct high level containment laboratories.
V zadnjih letih je precej držav, tudi tistih z manj sredstvi, namenjalo finančna sredstva za izgradnjo laboratorijev s potrebno visoko stopnjo biološke varnosti in zaščite.
While this should allow the country’s scientists to gain experience in the handling of dangerous pathogens like the SARS coronavirus, or viral hemorrhagic fever viruses, it may also bring about risks, especially in countries which are not able to reserve sufficient funds for the long-term maintenance of their facilities and do not provide adequate training for staff.
To naj bi sicer omogočilo znanstvenikom, da dobijo izkušnje za delo z nevarnimi patogeni, kot so virus sars-korona ali virusi hemoragičnih vročic, vendar pa je to lahko tudi nevarno, predvsem v državah, ki ne morejo nameniti zadostnih sredstev za dolgoročno vzdrževanje svojih objektov in ne zagotavljajo ustreznega usposabljanja osebja.
The occurrence of laboratory incidents and accidental releases of highly dangerous bio-materials due to inadequate bio-safety and bio-security practices in laboratories and other facilities, and lack of compliance with the UN infectious substance packaging and shipping regulations.
Primeri laboratorijskih nesreč in nenamernega izpusta zelo nevarnih bioloških snovi zaradi neustrezne biološke varnosti in biološke zaščite v laboratorijih in drugih objektih ter neupoštevanja pravil ZN o pakiranju in pošiljanju infektivnih snovi.
Three separate SARS laboratory accidents in Asia in 2003 and 2004 and the recent death from laboratory acquired Ebola haemorrhagic fever infection in Russia as well as deficiencies in bio-safety practices leading to laboratory acquired infections (tularemia and meliodosis) in the US are examples demonstrating the associated risks involved in inadequate bio-safety and laboratory bio-security, the improvement of which requires stronger commitment through management practices and the training of staff irrespective of the type of laboratory environment (human, animal or agricultural) in which the worker operates.
Kakšne nevarnosti so povezane z nezadostno biološko varnostjo in biološko zaščito v laboratorijih je razvidno iz treh ločenih laboratorijskih nesreč s sarsom v Aziji v letih 2003 in 2004, nedavnega smrtnega primera zaradi laboratorijske okužbe z Ebola hemoragično vročico v Rusiji ter iz laboratorijskih okužb v ZDA, do katerih je prišlo zaradi pomanjkljive biološke varnosti (tularemija in melioidoza); še bolj se je treba zavezati zagotavljanju biološke varnosti in biološke zaščite, in sicer z ustreznim upravljanjem in usposabljanjem osebja ne glede na laboratorijsko okolje, v katerem delajo (človeško, živalsko ali kmetijsko).
Project 1: Promotion of bio-risk reduction management through regional and national outreach
Projekt 1: Spodbujanje upravljanja za zmanjšanje bioloških nevarnosti z ozaveščanjem na regionalni in nacionalni ravni
The purpose of this project is to encourage States to assume responsibility for developing programmes to avoid accidental exposure or release and to prevent deliberate misappropriation or misuse of bio-agents in the laboratories.
Namen tega projekta je spodbuditi države, da prevzamejo odgovornost za pripravo programov za preprečevanje nenamernega izpostavljanja ali izpusta ter nezakonitega prilaščanja ali zlorab bioloških agensov v laboratorijih.
The project will involve national health policy makers as well as laboratory managers and laboratory staff to encourage their commitment to a bio-safety/bio-security culture.
Udeleženci bodo oblikovalci nacionalne zdravstvene politike ter vodstvo in osebje laboratorijev, projekt pa jih bo spodbujal, da se zavežejo zagotavljanju biološke varnosti/biološke zaščite.
The project will also contribute to the development of bio-risk reduction programmes at national, regional and international levels, including through the networking of laboratories and through a harmonised bio-safety and laboratory bio-security definition in the countries of the region, with the aim of promoting transparency and commitment to bioethics (including the promotion of non-proliferation).
Projekt bo prispeval tudi k razvoju programov za zmanjšanje bioloških nevarnosti na nacionalni, regionalni in mednarodni ravni, tudi z vzpostavljanjem povezav med laboratoriji ter enotno opredelitvijo biološke varnosti in biološke zaščite v laboratorijih v državah v regiji, s čimer bo spodbujal preglednost in zavezanost bioetiki (tudi neširjenja orožja za množično uničevanje).
Particular attention will be given to cross-sector networking between public health and other sectors such as animal health and the environment, to ensure a coordinated and comprehensive approach to bio-risk reduction.
Posebna pozornost bo posvečena medresorskemu povezovanju sektorja javnega zdravja in drugih sektorjev, npr. sektorjev za zdravje živali in okolje, kar naj bi zagotovilo usklajen in celovit pristop k zmanjševanju bioloških nevarnosti.
Regions and countries will become engaged in active dialogue on the issues related to the safety and security of dangerous bio-agents and toxins in laboratories and other facilities.
Vključitev regij in držav v dejaven dialog o vprašanjih varnosti in zaščite pred nevarnimi biološkimi agensi in toksini v laboratorijih in drugih objektih.
Existing laboratory bio-safety and bio-security practices will be mapped.
Popis obstoječih laboratorijskih praks pri biološki varnosti in biološki zaščiti.